Haemonetics to Present at The Raymond James Institutional Investors Conference
BRAINTREE, Mass., Feb. 25, 2013 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Brian Concannon, President & CEO, will present at The Raymond James Institutional Investors Conference in Orlando, Florida on March 6, 2013 at 8:40am Eastern time.
The public may access Mr. Concannon's presentation live via webcast at http://wsw.com/webcast/rj82/hae/.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
Gerry Gould, VP-Investor Relations
Tel. (781) 356-9402
Alt. (781) 356-9613
SOURCE Haemonetics Corporation
More by this Source
Haemonetics Provides Update on U.S. Whole Blood Supply Tender
Mar 24, 2014, 08:00 ET
Haemonetics to Present at the Raymond James 35th Annual Institutional Investors Conference
Feb 13, 2014, 08:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.